CohBar Inc
Change company Symbol lookup
Select an option...
CWBR CohBar Inc
DPLS Darkpulse Inc
CAT Caterpillar Inc
AMT American Tower Corp
SUI Sun Communities Inc
XTNT Xtant Medical Holdings Inc
BAC Bank of America Corp
VST Vistra Corp
AVOA Avoca LLC
LHRP Lifehouse Retirement Properties Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

CohBar, Inc. (CohBar), is a clinical stage biotechnology company. The Company is focused on the research and development of mitochondria-based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The Company has discovered more than 100 mitochondrial-derived peptides and is focused on the development of these peptides into therapeutics that offer the potential to address a broad range of diseases, including nonalcoholic steatohepatitis (NASH), obesity, cancer, fibrotic diseases including idiopathic pulmonary fibrosis (IPF), type 2 diabetes (T2D), cardiovascular and neurodegenerative diseases. The Company’s lead compound, CB4211, is in the phase 1b stage of a phase 1a/1b clinical trial for NASH and obesity. In addition, CohBar has four preclinical programs that include MBT5 Analogs (CXCR4 Antagonists) for Cancer and Other Disease Indicatio, MBT2 Analogs for Fibrotic Diseases, MBT3 Analog for Cancer Immunotherapy and CB5064 Analogs for Type 2 Diabetes.

Closing Price
$1.20
Day's Change
0.10 (9.09%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.22
Day's Low
1.11
Volume
(Light)
Volume:
228,022

10-day average volume:
346,242
228,022
  • Prev Close
    1.10
  • Today's Open
    1.16
  • Day's Range
    1.11-1.22
  • Avg Vol (10-day)
    346.2K
  • Last (time)
    3:59p ET 05/14/21
  • Last (size)
    100
  • 52-Wk Range
    0.85 - 2.84
    LowHigh
  • (06/05/20 - 08/27/20)
    41.18%
  • 93.8%
  • Market Cap
    74.1M
  • Shares Outstanding
    61.8M
  • -0.34
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.8
  • 13.63
  • (% of float 04/30/21)
    6.17

Latest News

May 03, 2021
9:00 am ET
Globe Newswire
April 27, 2021
8:30 am ET
Globe Newswire
April 23, 2021
7:27 am ET
MarketWatch
April 21, 2021
9:00 am ET
Globe Newswire
April 14, 2021
11:23 am ET
Globe Newswire
March 30, 2021
7:22 pm ET
Globe Newswire
2:45 pm ET
Accesswire
March 29, 2021
9:00 am ET
Globe Newswire
March 16, 2021
4:05 pm ET
Globe Newswire
9:00 am ET
Globe Newswire
March 12, 2021
9:00 am ET
Globe Newswire
March 02, 2021
9:00 am ET
Globe Newswire
February 25, 2021
9:00 am ET
Globe Newswire
December 17, 2020
6:21 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.